Research related

Medicine & Life Sciences

1. Pediatrics 100%
2. Neoplasms 84%
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma 52%
4. Child 49%
5. Acute Myeloid Leukemia 39%
6. Survival 34%
7. Wilms Tumor 31%
8. Therapeutics 31%
9. Glioma 31%
10. Cancer Survivors 30%
11. Recurrence 30%
12. Neuroblastoma 28%
13. Melanoma 23%
14. Mutation 22%
15. Diffuse Intrinsic Pontine Glioma 22%
16. Drug Therapy 20%
17. Progression-Free Survival 19%
18. Immunotherapy 19%
19. Leukemia 18%
20. Hematopoietic Stem Cell Transplantation 18%
21. Netherlands 17%
22. Young Adult 17%
23. Central Nervous System Neoplasms 17%
24. Glioblastoma 17%
25. Systematic Reviews 17%
26. Cell Transplantation 16%
27. Paraganglioma 14%
28. Guidelines 14%
29. DNA Methylation 13%
30. Cohort Studies 13%
31. Genes 13%
32. Pheochromocytoma 13%
33. Population 12%
34. Kidney 12%
35. B-Lymphoid Precursor Cells 12%
36. Vincristine 12%
37. Genome 11%
38. T-Lymphocytes 11%
39. Radiotherapy 11%
40. Organoids 11%
41. Quality of Life 11%
42. Atlases 11%
43. Dexamethasone 11%
44. Sleep 10%
45. Graft vs Host Disease 10%
46. Neoplasm Metastasis 10%
47. Transplants 10%
48. Sarcoma 10%
49. Allogeneic Cells 10%
50. Asparaginase 9%
51. Pharmacokinetics 9%
52. Incidence 9%
53. Kenya 9%
54. Pathology 9%
55. Registries 9%
56. Transplantation 9%
57. Retrospective Studies 9%
58. Practice Guidelines 9%
59. Meta-Analysis 8%
60. Peripheral Nervous System Diseases 8%
61. Rhabdomyosarcoma 8%
62. pembrolizumab 8%
63. Brain Neoplasms 8%
64. RNA Sequence Analysis 8%
65. Gene Fusion 8%
66. Income 8%
67. Residual Neoplasm 8%
68. Machine Learning 7%
69. Biomarkers 7%
70. Confidence Intervals 7%
71. Temozolomide 7%
72. Pandemics 7%
73. Survival Rate 7%
74. Medulloblastoma 7%
75. Clofarabine 7%
76. Methylation 7%
77. Mortality 7%
78. Epigenomics 7%
79. Fetal Blood 6%
80. Randomized Controlled Trials 6%
81. Brain 6%
82. Clinical Trials 6%
83. Parents 6%
84. ch14.18 monoclonal antibody 6%
85. Molecular Pathology 6%
86. Fertility Preservation 6%
87. Succinate Dehydrogenase 6%
88. Fatigue 6%
89. Renal Cell Carcinoma 6%
90. Survivors 6%
91. Pharmaceutical Preparations 6%
92. Astrocytoma 6%
93. Liquid Biopsy 6%
94. Indonesia 6%
95. Immunohistochemistry 5%
96. Hematopoietic Stem Cells 5%
97. Hodgkin Disease 5%
98. Bone Marrow 5%
99. Infections 5%
100. Rhabdoid Tumor 5%